Added to YB: 2024-01-04
Pitch date: 2024-01-04
CLRB [bullish]
Cellectar Biosciences, Inc.
-95.85%
current return
Author Info
@smantel is an ex-sell side analyst with a focus on fundamental research. Follow him on Twitter.
Company Info
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
Market Cap
$9.2M
Pitch Price
$87.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.04
P/E
-0.29
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
I like R/R set up going into the Monday A.M CC & Biotech showcase - $CLRB
$CLRB $2.90 lead drug targets cancer w/BBB penetration 5.5% short 11M float $80M EV Vs $FPRX 450% 2.32->10.43 $460M EV Narrowed competition PRIME/Fast Track '24 NDA? $21M cash+PIPE IP growth Risks: $JNJ mgmt analyst tgt $7-8 dilution
Read full article (2 min)